These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 19685192)

  • 1. Aberrant methylation profile of 14-3-3 sigma and its reduced transcription/expression levels in Chinese sporadic female breast carcinogenesis.
    Luo J; Feng J; Lu J; Wang Y; Tang X; Xie F; Li W
    Med Oncol; 2010 Sep; 27(3):791-7. PubMed ID: 19685192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promoter hypermethylation of the 14-3-3 sigma, SYK and CAGE-1 genes is related to the various phenotypes of urinary bladder carcinomas and associated with progression of transitional cell carcinomas.
    Kunze E; Wendt M; Schlott T
    Int J Mol Med; 2006 Oct; 18(4):547-57. PubMed ID: 16964403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.
    Pulukuri SM; Rao JS
    Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypermethylated 14-3-3-sigma and ESR1 gene promoters in serum as candidate biomarkers for the diagnosis and treatment efficacy of breast cancer metastasis.
    Zurita M; Lara PC; del Moral R; Torres B; Linares-Fernández JL; Arrabal SR; Martínez-Galán J; Oliver FJ; Ruiz de Almodóvar JM
    BMC Cancer; 2010 May; 10():217. PubMed ID: 20487521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer.
    Ferguson AT; Evron E; Umbricht CB; Pandita TK; Chan TA; Hermeking H; Marks JR; Lambers AR; Futreal PA; Stampfer MR; Sukumar S
    Proc Natl Acad Sci U S A; 2000 May; 97(11):6049-54. PubMed ID: 10811911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
    Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
    Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased expression of 14-3-3 sigma is associated with advanced disease in human epithelial ovarian cancer: its correlation with aberrant DNA methylation.
    Akahira J; Sugihashi Y; Suzuki T; Ito K; Niikura H; Moriya T; Nitta M; Okamura H; Inoue S; Sasano H; Okamura K; Yaegashi N
    Clin Cancer Res; 2004 Apr; 10(8):2687-93. PubMed ID: 15102672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer.
    Umbricht CB; Evron E; Gabrielson E; Ferguson A; Marks J; Sukumar S
    Oncogene; 2001 Jun; 20(26):3348-53. PubMed ID: 11423985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant stratifin overexpression is regulated by tumor-associated CpG demethylation in lung adenocarcinoma.
    Shiba-Ishii A; Noguchi M
    Am J Pathol; 2012 Apr; 180(4):1653-62. PubMed ID: 22310466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of 14-3-3sigma in ovary, prostate and endometrial carcinomas is associated with CpG island methylation.
    Mhawech P; Benz A; Cerato C; Greloz V; Assaly M; Desmond JC; Koeffler HP; Lodygin D; Hermeking H; Herrmann F; Schwaller J
    Mod Pathol; 2005 Mar; 18(3):340-8. PubMed ID: 15257317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CpG island methylation profile of estrogen receptor alpha in Iranian females with triple negative or non-triple negative breast cancer: new marker of poor prognosis.
    Ramezani F; Salami S; Omrani MD; Maleki D
    Asian Pac J Cancer Prev; 2012; 13(2):451-7. PubMed ID: 22524805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the Hypermethylated in Cancer gene (HIC-1) is associated with good outcome in human breast cancer.
    Nicoll G; Crichton DN; McDowell HE; Kernohan N; Hupp TR; Thompson AM
    Br J Cancer; 2001 Dec; 85(12):1878-82. PubMed ID: 11747329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collagen and calcium-binding EGF domains 1 is frequently inactivated in ovarian cancer by aberrant promoter hypermethylation and modulates cell migration and survival.
    Barton CA; Gloss BS; Qu W; Statham AL; Hacker NF; Sutherland RL; Clark SJ; O'Brien PM
    Br J Cancer; 2010 Jan; 102(1):87-96. PubMed ID: 19935792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CpG promoter methylation of the ALKBH3 alkylation repair gene in breast cancer.
    Stefansson OA; Hermanowicz S; van der Horst J; Hilmarsdottir H; Staszczak Z; Jonasson JG; Tryggvadottir L; Gudjonsson T; Sigurdsson S
    BMC Cancer; 2017 Jul; 17(1):469. PubMed ID: 28679371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 14-3-3sigma gene silencing during melanoma progression and its role in cell cycle control and cellular senescence.
    Schultz J; Ibrahim SM; Vera J; Kunz M
    Mol Cancer; 2009 Jul; 8():53. PubMed ID: 19642975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-hit inactivation of FHIT by loss of heterozygosity and hypermethylation in breast cancer.
    Yang Q; Nakamura M; Nakamura Y; Yoshimura G; Suzuma T; Umemura T; Shimizu Y; Mori I; Sakurai T; Kakudo K
    Clin Cancer Res; 2002 Sep; 8(9):2890-3. PubMed ID: 12231533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent CpG methylation of ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) in sporadic and hereditary Tunisian breast cancer patients: clinical significance.
    Trifa F; Karray-Chouayekh S; Jmaa ZB; Jmal E; Khabir A; Sellami-Boudawara T; Frikha M; Daoud J; Mokdad-Gargouri R
    Med Oncol; 2013 Mar; 30(1):418. PubMed ID: 23315218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple promoters of catechol-O-methyltransferase gene are selectively inactivated by CpG hypermethylation in endometrial cancer.
    Sasaki M; Kaneuchi M; Sakuragi N; Dahiya R
    Cancer Res; 2003 Jun; 63(12):3101-6. PubMed ID: 12810635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of 14-3-3 sigma (σ) promoter methylation as a noninvasive biomarker using blood samples for breast cancer diagnosis.
    Ye M; Huang T; Ying Y; Li J; Yang P; Ni C; Zhou C; Chen S
    Oncotarget; 2017 Feb; 8(6):9230-9242. PubMed ID: 27999208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypermethylation of tumor suppressor genes BRCA1, p16 and 14-3-3sigma in serum of sporadic breast cancer patients.
    Jing F; Zhang J; Tao J; Zhou Y; Jun L; Tang X; Wang Y; Hai H
    Onkologie; 2007 Feb; 30(1-2):14-9. PubMed ID: 17264521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.